nicorette fruit 4 mg sugetabletter
mcneil denmark aps - nicotineresinat - sugetabletter - 4 mg
nikorono fruit 2 mg medicinsk tyggegummi
originalis b.v. - nicotineresinat - medicinsk tyggegummi - 2 mg
nikorono fruit 4 mg medicinsk tyggegummi
originalis b.v. - nicotineresinat - medicinsk tyggegummi - 4 mg
nicochew fruitmint 2 mg medicinsk tyggegummi
evolan pharma ab - nicotin-resin kompleks 20% - medicinsk tyggegummi - 2 mg
ovitrelle
merck europe b.v. - choriogonadotropin alfa - anovulation; reproductive techniques, assisted; infertility, female - køn hormoner og modulatorer af den genitale system, - ovitrelle er indiceret til behandling af:kvinder, der gennemgår superovulation forud for assisteret befrugtning, såsom in vitro-fertilisering (ivf): ovitrelle gives til at udløse endelige follikulært modning og luteinisation efter stimulation af follikulære vækst;anovulatory eller oligo-ovulatoriske kvinder: ovitrelle gives for at fremkalde ægløsning og luteinisation i anovulatory eller oligo-ovulatoriske patienter efter stimulation af follikulære vækst.
rekovelle
ferring pharmaceuticals a/s - follitropin delta - anovulation - køn hormoner og modulatorer af den genitale system, - kontrolleret ovariestimulation for udviklingen af flere follikler hos kvinder undergår assisterede reproduktive teknologier (art) som en in vitro-befrugtning (ivf) eller intracytoplasmatisk sperm injektion (icsi) cyklus.
it-cypermethrin suspensionskoncentrat
inter-trade a/s - cypermethrin - suspensionskoncentrat - 100 g/l cypermethrin
nicochew fruitmint 4 mg medicinsk tyggegummi
evolan pharma ab - nicotin-resin kompleks 20% - medicinsk tyggegummi - 4 mg
fibro emulsionskoncentrat
belchim crop protection nv/sa - paraffinolie - emulsionskoncentrat - 797 g/l paraffinolie (1)
bemfola
gedeon richter plc. - follitropin alfa - anovulation - køn hormoner og modulatorer af den genitale system, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. i kliniske forsøg skal disse patienter blev defineret ved en endogen serum lh niveau < 1. 2 ie / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.